167 related articles for article (PubMed ID: 18324929)
1. High circulating levels of RBP4 and mRNA levels of aP2, PGC-1alpha and UCP-2 predict improvement in insulin sensitivity following pioglitazone treatment of drug-naïve type 2 diabetic subjects.
Hammarstedt A; Pihlajamäki J; Graham TE; Kainulainen S; Kahn BB; Laakso M; Smith U
J Intern Med; 2008 Apr; 263(4):440-9. PubMed ID: 18324929
[TBL] [Abstract][Full Text] [Related]
2. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone.
Yao-Borengasser A; Varma V; Bodles AM; Rasouli N; Phanavanh B; Lee MJ; Starks T; Kern LM; Spencer HJ; Rashidi AA; McGehee RE; Fried SK; Kern PA
J Clin Endocrinol Metab; 2007 Jul; 92(7):2590-7. PubMed ID: 17595259
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study.
Tripathy D; Daniele G; Fiorentino TV; Perez-Cadena Z; Chavez-Velasquez A; Kamath S; Fanti P; Jenkinson C; Andreozzi F; Federici M; Gastaldelli A; Defronzo RA; Folli F
Diabetologia; 2013 Oct; 56(10):2153-63. PubMed ID: 23811853
[TBL] [Abstract][Full Text] [Related]
4. Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar fatty rats and in cultured adipocytes.
Matsuda J; Hosoda K; Itoh H; Son C; Doi K; Hanaoka I; Inoue G; Nishimura H; Yoshimasa Y; Yamori Y; Odaka H; Nakao K
Diabetes; 1998 Nov; 47(11):1809-14. PubMed ID: 9792555
[TBL] [Abstract][Full Text] [Related]
5. Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects.
Hammarstedt A; Sopasakis VR; Gogg S; Jansson PA; Smith U
Diabetologia; 2005 Jan; 48(1):96-104. PubMed ID: 15624096
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial.
Coletta DK; Sriwijitkamol A; Wajcberg E; Tantiwong P; Li M; Prentki M; Madiraju M; Jenkinson CP; Cersosimo E; Musi N; Defronzo RA
Diabetologia; 2009 Apr; 52(4):723-32. PubMed ID: 19169664
[TBL] [Abstract][Full Text] [Related]
7. Thiazolidinedione addition reduces the serum retinol-binding protein 4 in type 2 diabetic patients treated with metformin and sulfonylurea.
Lin KD; Chang YH; Wang CL; Yang YH; Hsiao PJ; Li TH; Shin SJ
Transl Res; 2008 Jun; 151(6):309-14. PubMed ID: 18514142
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone lowers serum retinol binding protein 4 by suppressing its expression in adipose tissue of obese rats.
Zhu C; Xiao Y; Liu X; Han J; Zhang J; Wei L; Jia W
Cell Physiol Biochem; 2015; 35(2):778-88. PubMed ID: 25634757
[TBL] [Abstract][Full Text] [Related]
9. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.
Yu JG; Javorschi S; Hevener AL; Kruszynska YT; Norman RA; Sinha M; Olefsky JM
Diabetes; 2002 Oct; 51(10):2968-74. PubMed ID: 12351435
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes.
Tonelli J; Li W; Kishore P; Pajvani UB; Kwon E; Weaver C; Scherer PE; Hawkins M
Diabetes; 2004 Jun; 53(6):1621-9. PubMed ID: 15161771
[TBL] [Abstract][Full Text] [Related]
11. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
[TBL] [Abstract][Full Text] [Related]
12. Baseline adiponectin levels do not influence the response to pioglitazone in ACT NOW.
Tripathy D; Clement SC; Schwenke DC; Banerji M; Bray GA; Buchanan TA; Gastaldelli A; Henry RR; Kitabchi AE; Mudaliar S; Ratner RE; Stentz FB; Musi N; Reaven PD; DeFronzo RA
Diabetes Care; 2014 Jun; 37(6):1706-11. PubMed ID: 24705615
[TBL] [Abstract][Full Text] [Related]
13. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
[TBL] [Abstract][Full Text] [Related]
14. Increased adiposity and reduced adipose tissue mRNA expression of uncoupling protein-2 in first-degree relatives of type 2 diabetic patients: evidence for insulin stimulation of UCP-2 and UCP-3 gene expression in adipose tissue.
Pedersen SB; Nyholm B; Kristensen K; Nielsen MF; Schmitz O; Richelsen B
Diabetes Obes Metab; 2005 Jan; 7(1):98-105. PubMed ID: 15642081
[TBL] [Abstract][Full Text] [Related]
15. [Expression and regulation of retinol binding protein 4 mRNA in human adipose tissue in obese and type 2 diabetics].
Liu XH; Wei L; Wang LY; Zhu CY; Bao YQ; Jia WP
Zhonghua Yi Xue Za Zhi; 2010 May; 90(18):1251-4. PubMed ID: 20646597
[TBL] [Abstract][Full Text] [Related]
16. Retinol-binding protein 4 in polycystic ovary syndrome--association with steroid hormones and response to pioglitazone treatment.
Aigner E; Bachofner N; Klein K; De Geyter C; Hohla F; Patsch W; Datz C
J Clin Endocrinol Metab; 2009 Apr; 94(4):1229-35. PubMed ID: 19158194
[TBL] [Abstract][Full Text] [Related]
17. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.
Miyazaki Y; Mahankali A; Matsuda M; Mahankali S; Hardies J; Cusi K; Mandarino LJ; DeFronzo RA
J Clin Endocrinol Metab; 2002 Jun; 87(6):2784-91. PubMed ID: 12050251
[TBL] [Abstract][Full Text] [Related]
18. Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of type 2 diabetes.
Kim H; Haluzik M; Gavrilova O; Yakar S; Portas J; Sun H; Pajvani UB; Scherer PE; LeRoith D
Diabetologia; 2004 Dec; 47(12):2215-25. PubMed ID: 15662559
[TBL] [Abstract][Full Text] [Related]
19. Retinol-binding protein 4 in twins: regulatory mechanisms and impact of circulating and tissue expression levels on insulin secretion and action.
Ribel-Madsen R; Friedrichsen M; Vaag A; Poulsen P
Diabetes; 2009 Jan; 58(1):54-60. PubMed ID: 18852328
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone treatment enlarges subcutaneous adipocytes in insulin-resistant patients.
Koenen TB; Tack CJ; Kroese JM; Hermus AR; Sweep FC; van der Laak J; Stalenhoef AF; de Graaf J; van Tits LJ; Stienstra R
J Clin Endocrinol Metab; 2009 Nov; 94(11):4453-7. PubMed ID: 19820024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
